Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma(1)

Background: The therapeutic paradigm of metastatic urothelial carcinoma (UC) is rapidly shifting and new biomarkers are needed to enhance patient selection. Objective: Early identification of dynamic predictors of outcome may be a key to optimize the sequence of effective therapies in metastatic UC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Bladder Cancer
Autores principales: Fina, Emanuela, Necchi, Andrea, Giannatempo, Patrizia, Colecchia, Maurizio, Raggi, Daniele, Daidone, Maria Grazia, Cappelletti, Vera
Formato: Artigo
Lenguaje:Inglês
Publicado: IOS Press 2016
Materias:
Research Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5181661/
https://ncbi.nlm.nih.gov/pubmed/28035320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-160069
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares